In late 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged
as the cause of a cluster of pneumonia cases in China, and the corresponding disease was …

Abstract Since December 2019, a novel Coronavirus (SARS-CoV-2) was confirmed as the
etiologic agent of a worldwide outbreak of a pneumonia that can result in severe respiratory …

Abstract The Coronavirus Disease 2019 (COVID 19) has been reported in almost every
country in the world. Although a large proportion of infected individuals develop only mild …

There remains a high risk of thrombosis in patients affected by the SARS-CoV-2 virus and
recent reports have shown pulmonary embolism (PE) as a cause of sudden death in these …

Scarce data exist regarding the clinical sequelae of COVID-19 and/or the prevalence of
thromboembolic disease in asymptomatic patients. Surely, there is increased prevalence of …

A COVID-19–positive patient presented with pleuritic chest pain and cough and was found
to have acute pulmonary embolisms (APEs). There has been an increase in observational …

Infection by SARS-Cov-2 is mainly characterized by fever and respiratory symptoms, with
dyspnea and lung infiltrates in more severe cases [1]. Many patients also present with a pro …

Abstract Introduction Coronavirus disease 2019 (COVID-19) has been associated with
cardiovascular complications and coagulation disorders. Previous studies reported …

Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease that primarily affects
the respiratory system, but it may cause cardiovascular complications such as …

Background Preliminary reports have described significant procoagulant events in patients
with coronavirus disease-2019 (COVID-19), including life-threatening pulmonary embolism …